The FASEB Journal, Vol 11, 591-599, Copyright © 1997 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage

CO Bellamy, AR Clarke, AH Wyllie and DJ Harrison
Department of Pathology, University Medical School, Edinburgh, Scotland, U.K.

Despite good evidence for p53 dysfunction in human hepatocellular carcinomas, little is known of the significance of p53 to normal hepatocytes and whether p53 dysfunction is relevant to early hepatocarcinogenesis. We have therefore examined the consequences of targeted p53 deficiency in hepatocytes for regulation of apoptosis, proliferation, and ploidy. p53 deficiency was silent in normal liver and did not affect progression from diploidy to polyploidy in the aging liver. However, in primary culture the absence of p53 resulted in increased hepatocyte proliferation indices and decreased sensitivity to proliferation inhibition by TGFbeta. Moreover, p53-deficient cells continued to survive and proliferate under conditions of minimal trophic support that led to growth arrest and apoptosis of wild-type cells. In vivo, p53-deficient mice had enhanced proliferative responses to both xenobiotic hepatomitogen and CCl4-induced liver necrosis, although lack of persistent proliferation showed that other control mechanisms are important. There was no simple relationship between p53 and apoptosis after DNA damage because UV irradiation led to p53- independent apoptosis, even though p53 was stabilized. However, p53 did couple DNA damage to growth arrest, and abnormal mitoses after gamma- irradiation of regenerating p53 null livers demonstrated circumstances where loss of G1 and G2 checkpoints may generate abnormal ploidy. Thus p53 becomes important when hepatocytes are released from G0 and stressed, sensitizing them to mitogen and cytokine regulators of cell cycle progression and apoptosis. Hence p53 deficiency is likely to be significant in an environment of persistent regenerative stimuli and unfavorable trophic support or in the presence of other enabling genetic lesions. This model is relevant to human hepatocarcinogenesis, which almost always occurs against a background of chronic hepatocellular destruction in hepatitis and cirrhosis. In that context, by reducing the need for cytokine support and disabling DNA damage- induced growth arrest, p53 deficiency should facilitate the expansion of preneoplastic clones in chronic liver disease.

This article has been cited by other articles:

				P. A. Farazi, J. Glickman, J. Horner, and R. A. DePinho Cooperative Interactions of p53 Mutation, Telomere Dysfunction, and Chronic Liver Damage in Hepatocellular Carcinoma Progression. Cancer Res., May 1, 2006; 66(9): 4766 - 4773. [Abstract] [Full Text] [PDF]

				A. T. C. Lee, J. Ren, E.-T. Wong, K. H. K. Ban, L. A. Lee, and C. G. L. Lee The Hepatitis B Virus X Protein Sensitizes HepG2 Cells to UV Light-induced DNA Damage J. Biol. Chem., September 30, 2005; 280(39): 33525 - 33535. [Abstract] [Full Text] [PDF]

				A Oniscu, N Sphyris, R G Morris, S Bader, and D J Harrison p73{alpha} is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes J. Clin. Pathol., May 1, 2004; 57(5): 492 - 498. [Abstract] [Full Text] [PDF]

				J. C. Cusack Jr. Overcoming Antiapoptotic Responses to Promote Chemosensitivity in Metastatic Colorectal Cancer to the Liver Ann. Surg. Oncol., October 1, 2003; 10(8): 852 - 862. [Abstract] [Full Text] [PDF]

				J.-E. Guidotti, O. Bregerie, A. Robert, P. Debey, C. Brechot, and C. Desdouets Liver Cell Polyploidization: A Pivotal Role for Binuclear Hepatocytes J. Biol. Chem., May 23, 2003; 278(21): 19095 - 19101. [Abstract] [Full Text] [PDF]

				S. Prost, S. Sheahan, D. Rannie, and D. J. Harrison Adenovirus-mediated Cre deletion of floxed sequences in primary mouse cells is an efficient alternative for studies of gene deletion Nucleic Acids Res., August 15, 2001; 29(16): e80 - e80. [Abstract] [Full Text] [PDF]

				P Starkel, L Lambotte, C Sempoux, C De Saeger, A Saliez, D Maiter, and Y Horsmans After portal branch ligation in the rat, cellular proliferation in associated with selective induction of c-Ha-ras, p53, cyclin E, and Cdk2 Gut, July 1, 2001; 49(1): 119 - 130. [Abstract] [Full Text] [PDF]

				J. C. Cusack Jr., R. Liu, M. Houston, K. Abendroth, P. J. Elliott, J. Adams, and A. S. Baldwin Jr. Enhanced Chemosensitivity to CPT-11 with Proteasome Inhibitor PS-341:: Implications for Systemic Nuclear Factor-{{kappa}}B Inhibition Cancer Res., May 1, 2001; 61(9): 3535 - 3540. [Abstract] [Full Text]

				C. J. Kemp, S. Sun, and K. E. Gurley p53 Induction and Apoptosis in Response to Radio- and Chemotherapy in Vivo Is Tumor-Type-dependent Cancer Res., January 1, 2001; 61(1): 327 - 332. [Abstract] [Full Text]

				S. C. Hasmall and R. A. Roberts The Nongenotoxic Hepatocarcinogens Diethylhexylphthalate and Methylclofenapate Induce DNA Synthesis Preferentially in Octoploid Rat Hepatocytes Toxicol Pathol, July 1, 2000; 28(4): 503 - 509. [Abstract] [PDF]

				D. A. Delker, B. L. Yano, and B. B. Gollapudi Evaluation of Cytotoxicity, Cell Proliferation, and Genotoxicity Induced by p-Cresidine in Hetero- and Nullizygous Transgenic p53 Mice Toxicol. Sci., June 1, 2000; 55(2): 361 - 369. [Abstract] [Full Text] [PDF]

				S. Prost, J. M. Ford, C. Taylor, J. Doig, and D. J. Harrison Hepatitis B x Protein Inhibits p53-dependent DNA Repair in Primary Mouse Hepatocytes J. Biol. Chem., December 11, 1998; 273(50): 33327 - 33332. [Abstract] [Full Text] [PDF]

				S. Prost, C. O. C. Bellamy, D. S. Cunningham, and D. J. Harrison Altered DNA repair and dysregulation of p53 in IRF-1 null hepatocytes FASEB J, February 1, 1998; 12(2): 181 - 188. [Abstract] [Full Text]